CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 136 filers reported holding CYTOKINETICS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $119,000 | -23.7% | 16,530 | -13.6% | 0.04% | -21.6% |
| Q4 2017 | $156,000 | -46.8% | 19,130 | -5.3% | 0.05% | -47.4% |
| Q3 2017 | $293,000 | -40.1% | 20,200 | -50.0% | 0.10% | -30.7% |
| Q2 2017 | $489,000 | -20.1% | 40,418 | -15.1% | 0.14% | -4.1% |
| Q1 2017 | $612,000 | – | 47,618 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |